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Mass spectrometryO-mannosylation is a vital protein modiﬁcation. In humans, defective O-mannosylation of a-dystro-
glycan results in severe congenital muscular dystrophies. However, other proteins bearing this mod-
iﬁcation in vivo are still largely unknown. Here, we describe a highly reliable method combining
glycosidase treatment with LC–MS analyses to identify mammalian O-mannosylated proteins from
tissue sources. Our workﬂow identiﬁed T-cadherin (H-cadherin, CDH13) as a novel O-mannosylated
protein. In contrast to known O-mannosylated proteins, single mannose residues (Man-a-Ser/Thr)
are attached to this cell adhesionmolecule. Conserved O-glycosylation sites in T-, E- and N-cadherins
from different species, point to a general role of O-mannosyl glycans for cadherin function.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glycosylation is one of the most prominent and complex post-
translational protein modiﬁcations and contributes to various cel-
lular processes including cell–cell and receptor–ligand interactions
[1]. In the case of O-mannosylation, carbohydrate chains are at-
tached via an O-linked a-mannose to serine or threonine residues
of the protein. This conserved modiﬁcation is essential for growth
and development of fungi and animals [2,3].
O-mannosylation in mammals starts in the endoplasmic reticu-
lum (ER), with the addition of a single mannose to nascent poly-
peptide chains by the protein O-mannosyltransferase POMT1/
POMT2 complex [4]. Subsequently, various glycosyltransferases
contribute to the elongation of the carbohydrate chain in the Golgi
apparatus [5]. Glycan analyses from various tissue sources and cell
lines revealed diverse O-mannose-initiated glycan structures rang-
ing from single mannose to complex bi-antennary chains [6].So far, the best characterized mammalian O-mannosylated pro-
tein is a-dystroglycan (a-DG) which carries diverse O-mannosyl
glycans including the core structure Siaa3Galß4GlcNAcß2Mana-
Ser/Thr and an unusual O-mannosyl glycan containing mannose-
6-phosphate [7–9]. The latter produces a branched chain that is ex-
tended with repeating disaccharide units of [-3-xylose-a1,3-glucu-
ronic acid-b1-] and mediates the binding between a-DG and
laminin [10]. Consequently, defective O-mannosylation results in
severe congenital muscular dystrophies such as Walker–Warburg
syndrome (WWS) [11]. Interestingly, only a small number of addi-
tional O-mannosylated proteins have been identiﬁed until now.
These include the cell surface glycoprotein CD24 [12], the protein
tyrosine phosphatase receptor protein PTPRZ1 [13], the cell adhe-
sion protein neurofascin [14], and the lecticans neurocan and vers-
ican [15].
Identiﬁcation of target proteins is challenging since signature
sequences for O-mannosylation have not been identiﬁed yet. Fur-
ther, occurrence of different O-linked hexose isomers that may
be heterogeneously elongated hamper mass spectrometric (MS)-
based methods which are not able to discriminate between sugar
isomers such as glucose and mannose, and are still limited towards
simple carbohydrate structures. In this study, we redress these
problems by combining glycosidase treatment, lectin enrichment
and liquid chromatography (LC)–MS analyses in order to discover
O-mannosylated proteins directly from native tissue. As proof of
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herin, CDH13) from rabbit skeletal muscle as novel O-mannosylat-
ed protein.2. Materials and methods
2.1. Mannosidase treatment
Mannosidase treatment was performed at 37 C in a-mannosi-
dase buffer (0.1 M sodium acetate, 2 mM ZnCl, pH 5.0) containing
1.5 Units per ml (U/ml) of a(1-2,3,6)-mannosidase (Canavalia
ensiformis, Prozyme). a-DG-derived peptides LSDAGT(O-a-man)-
VVSGQIR (DG1man), LETAS(O-a-man)PPTR (DG2man) and
LETASPPT(O-a-man)R (DG3man) [8] were custom synthesized by
ThermoScientiﬁc. One nanomolar of DG1man, 1 nM H4-dimethy-
lated DG2man, and 1 nM D4-dimethylated DG3man [16] were
incubated with a-mannosidase for 4 h or mock treated. Glycopro-
tein-derived peptides (see below) were treated overnight.
a-Mannosidase was removed by ultraﬁltration (14000g at 25 C
for 10 min) and the ﬁlter membrane (Microcon 30, Millipore)
was washed once with 15 ll of 0.1% TFA. Peptide and acidic wash
fraction were combined and analyzed by LC–MS.
2.2. Glycoprotein enrichment
a-DG-enriched glycoprotein fraction was prepared from rabbit
skeletal muscle as previously described in [17]. Puriﬁcation was
limited to diethylaminoethyl (DEAE)-Sepharose (GE Healthcare)
ion exchange and wheat germ agglutinin (WGA) agarose (Vector
Laboratories) lectin-afﬁnity chromatography. Enrichment of a-DG
was veriﬁed by Western blotting.
2.3. Enrichment and labeling of O-mannosyl peptides
Two hundred micrograms of a-DG-enriched glycoprotein frac-
tion was digested by 1 lg of trypsin (Promega) using an adapted
N-Glyco-ﬁlter-aided sample preparation (FASP) method [18].
Microcon 30 ﬁlter units were used. After overnight incubation
peptides were eluted and treated with 500 U/ml of glycerol free
peptide-N-glycosidase F (PNGase F; NEB), 40000 U/ml of O-glyco-
sidase (endo-a-N-acetylgalactosaminidase; NEB), 50 U/ml of neur-
aminidase (NEB), 8 U/ml of b(1–4)-galactosidase (NEB) and 4 U/ml
of b-(N)-acetylglucosaminidase (NEB) in 50 mM NaH2PO4, pH 7.5
at 37 C for 16 h. After removal of the enzymes by ultraﬁltration,
1 nM DG1man was added to the peptide solution as internal con-
trol. 100 ll of Concanavalin A (ConA; Sigma) solution (0.6 mg ConA
in 2 mM CaCl2, 2 mM MnCl2, 1 M NaCl, 40 mM Tris–HCl, pH 7.3)
was added. After incubation for 1 h at room temperature, unbound
peptides were removed by ultraﬁltration. ConA-bound material
was washed six times with 50 ll of 1 mM CaCl2, 1 mM MnCl2,
0.5 M NaCl, 20 mM Tris–HCl, pH 7.3. Peptides were eluted with
60 ll of 0.3 M a-glucose in the same buffer. Twenty ﬁve microlitres
of each of the eluate were H4-dimethylated (light) or D4-dimethy-
lated (medium) [16]. After labeling, samples were treated with
a-mannosidase as described above.
2.4. Liquid chromatography and mass spectrometric analysis
For LC–MS analysis a nanoAcquity UPLC (Waters) was used cou-
pled to an LTQ Orbitrap XL MS (ThermoScientiﬁc). Peptides were
trapped and desalted (5 lm Symmetry 180 lm  20 mm, Waters)
at a ﬂow rate of 15 ll/min with solution A (0.1% formic acid). After
12 min of loading and washing, peptides were eluted to an analyt-
ical column (75 lm  250 mm, 1.7 lm BEH130 C18 column,Waters) and separated using a 40 min gradient from 3% to 40% of
solution B (90% acetonitrile, 0.1% formic acid) and subsequently a
20 min gradient from 40% to 90% of solution B at 200 nl/min.
Full-scan mass spectra were acquired in the Orbitrap analyzer in
the positive ion mode at 60000 resolution using m/z 445.1200 as
lock-mass for internal recalibration, followed by collision-induced
dissociation (CID) fragmentation of the six most intense ions. CID
spectra were acquired in the centroid mode using an ion trap
detector. MS3 experiments were done in a data independent mode
using the ﬁrst fragmentation event to remove the glycan followed
by a second fragmentation of the de-glycosylated peptide. For con-
trol experiments Escherichia coli tryptic digest (Waters) was used.
2.5. Data processing and sequence alignments
Extracted ion chromatograms were done using the Qual brow-
ser software (ThermoScientiﬁc) with the calculated peptide mass
and a tolerance of 10 ppm. When necessary manual recalibration
was done using the average deviation calculated from all identiﬁed
peptides.
MS data were analyzed by MaxQuant (version 1.3.0.5) and
Andromeda search engine [19] with standard settings except noted
otherwise. Proteins were searched against the UniProt rabbit data-
base (downloaded 06/29/2012) extended with the synthetic pep-
tide sequence LSDAGVTTSGQIR (DG1). Carbamidomethylation of
cysteine was set as ﬁxed, and methionine oxidation and aspara-
gine/glutamine deamidation was set as variable modiﬁcation. For
quantitation light and medium dimethyl label were added for the
N-terminus and lysine. A minimal peptide length of 7 amino acids,
and at maximum two miscleavages were allowed. The maximum
protein, peptide and site false discovery rates (FDR) were set to
0.05. ‘‘Re-quantify’’ and ‘‘Match between runs (2 min)’’ was acti-
vated. Automatic bioinformatics data analysis was done with
Perseus.
Multiple sequence alignments were prepared using ClustalW2
[20] and rendering was done using BoxShade (http://www.ch.emb-
net.org/software/BOX_form.html).3. Results
3.1. Workﬂow to identify O-mannosylated peptides in complex
biological samples
To identify O-mannosylated proteins from mammalian tissues
we wished to take advantage of mass spectrometry (MS), since
protein identiﬁcation by this technology after tryptic digest is a
highly sensitive method, by which peptide sequences are obtained
from fragments of the peptide backbone after CID. However, due to
lability of the glycosidic bond, no amino acid sequence information
is obtained from the majority of glycopeptides due to dominant
neutral loss of glycans upon CID. We developed a workﬂow
(Fig. 1) that allowed us to overcome this problem, to handle heter-
ogeneity of glycans and to distinguish mannose from other hexose
isomers linked in O-glycosidic bond to serine and threonine.
In general, our approach aimed to generate glycopeptides bear-
ing predominantly O-linked mannoses, and to extract those from
complex peptide mixtures by the mannose-binding lectin ConA.
Further, we sought to identify O-mannosylated peptides by com-
bining the enzymatic speciﬁcity of a-mannosidase with quantita-
tive mass spectrometry after stable isotope labeling. In Fig. 1, the
basic steps of our workﬂow are depicted. After protease digest,
peptides/glycopeptides were treated simultaneously (i) with PNG-
ase F to remove N-linked glycans, (ii) with neuraminidase and O-
glycosidase to remove Core 1 and Core 3 O-linked saccharides,
and (iii) with neuraminidase, b(1–4)-galactosidase and b-(N)-acet-
Fig. 1. Workﬂow to detect O-mannosylated peptides. For detailed description see
Section 3.1. Glycopeptides bearing O-linked mannose residues (grey circles) are
depicted. Stars indicate dimethyl label.
Fig. 2. Mannosidase treatment of synthetic peptides. The O-mannosylated peptides
DG1man, DG2man and DG3man were treated with or without a-mannosidase and
analyzed by LC–MS. The six lanes show overlays of XICs for the treated (solid line)
and untreated (dashed line) sample. De-mannosylated peptides are only detected
upon enzyme treatment (lanes 2,4 and 6). L = light dimethyl label; M = medium
dimethyl label.
P.R. Winterhalter et al. / FEBS Letters 587 (2013) 3715–3721 3717ylglucosaminidase to trim back the majority of O-mannosyl gly-
cans to a single mannose residue. After ConA-afﬁnity chromatogra-
phy, samples were divided in half in order to label peptides with
either normal or deuterated formaldehyde [16]. One of the samples
was treated with a-mannosidase. After inactivation and removal of
the enzyme, this sample was mixed with the mock treated pep-
tides and analyzed by LC–MS. To decrease the number of false po-
sitive results, label swap experiments were performed. Peptides
unaffected by the enzyme were detected as peak pairs in the MS-
spectra with intensity ratios of approximately one. In contrast,
de-mannosylated peptides appeared with high intensity ratios
depending on the level of noise and contaminants. A basic require-
ment for this quantitative comparison is the identiﬁcation of the
peptides, which in most cases is only possible for the de-glycosyl-
ated form but not for the glycosylated match which shows a dom-
inant neutral loss of a hexose upon CID, but rarely sequenceinformation. Analyses of the complex datasets were done using
the MaxQuant software, which calculates intensity ratios for all
medium and light labeled peptide matches identiﬁed by the imple-
mented Andromeda software. The visualization and statistical cal-
culations are done using the Perseus software. Signiﬁcant intensity
ratios calculated by Benjamini–Hochberg FDR two-sided test
(threshold value of 0.005) were used to identify candidate pep-
tides. Analysis of a synthetic O-mannosylated peptide in a complex
peptide mixture (E. coli tryptic digest) resulted in a false positive
discovery rate of less than 0.02% (data not shown).
3.2. Enzymatic de-glycosylation using a-mannosidase from Jack bean
Our workﬂow is based on the enzymatic release of O-linked
mannose from enriched glycopeptides. Testing the efﬁciency of dif-
ferent a-mannosidases using a-DG-derived O-mannosylated pep-
tides we found that a(1–2,3,6)-mannosidase from Jack bean
worked best for our purposes. After 4 h of incubation with this en-
zyme peptides were analyzed by LC–MS. Peptides LSDAGT(O-a-
man)VVSGQIR (DG1man) and LETAS(O-a-man)PPTR (DG2man)
were quantitatively de-glycosylated, as indicated in the extracted
ion chromatogram by a decrease in mass of one hexose (Fig. 2,
compare lanes 1 and 5 with lanes 2 and 6, respectively). In con-
trast, under the same conditions most of the peptide LET-
ASPPT(O-a-man)R (DG3man) remained unaffected (Fig. 2,
compare lanes 3 and 4). These results showed that a-mannosidase
from Jack bean is a powerful tool to remove O-linked mannoses
bound to serine as well as threonine residues of glycopeptides.
However, release efﬁciency might vary, depending on primary
and/or secondary structure features of the peptide.
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fractions from rabbit skeletal muscle
To validate our workﬂow we prepared an a-DG-enriched glyco-
protein fraction from rabbit skeletal muscle as detailed in Section
2. Glycoproteins were digested with trypsin and peptide DG1man
(1 nM) was added as an internal control. After glycosidase treat-
ment, ConA-enrichment, and dimethyl labeling, H4-dimethylated
(light) and D4-dimethylated (medium) glycopeptides were a-man-
nosidase and mock treated, respectively. After inactivation of the
enzyme, samples were mixed and analyzed by LC–MS. In total,
three independent biological replicates were analyzed and for each
sample a label-swap replicate was done. More than 500 individual
peptides were identiﬁed. Ratios of signal intensities of mannosi-
dase-treated versus untreated peptides of label-swap experiments
were plotted against each other (Fig. 3A). For most of the 500 pep-
tides ratios were approximately one, including peptides showing
unspeciﬁc binding to ConA and/or resistance to mannosidase treat-
ment. In contrast, the internal control peptide DG1man and the a-
DG-derived peptide VSDAGTVVSGQIR were detected with signiﬁ-
cant intensity ratios. VSDAGTVVSGQIR has been previously identi-
ﬁed as di-mannosylated peptide which has prevalently O-
mannosyl glycans of the structure Galß4GlcNAcß2Mana-Ser/Thr
[8,21]. Thus, in a next step MS spectra of mock treated samples
were screened for potential single or multiple mannosylated forms
of VSDAGTVVSGQIR using the high mass accuracy of the Orbitrap
analyzer. In agreement with other studies [8,21], exclusively the
twofold mannosylated peptide was detected in extracted-ion chro-
matograms (XIC) (Fig. S1A). Fragment spectra acquired for this pre-
cursor mass conﬁrmed the identity of the double mannosylated
peptide (Fig. S2A and B). We further detected another hexosylatedFig. 3. Identiﬁcation of O-mannosylated peptides. (A) Glycoproteins isolated from rabbit
ratios of identiﬁed peptides from three independent experiments versus label swap replic
three peptides with signiﬁcant intensity ratios were observed: a-DG-derived peptide
EGPYVGHVMEGSPTGTTVMR. (B) Peptides were prepared according to the workﬂow desc
Two T-Cad-derived peptides described in (A) were detected. (C and D) MS3 analysis of
999.95m/z leads to a fragment ion of 918.93m/z formed by a dominant neutral loss of the
now leading to b and y ions caused by backbone fragmentation of a peptide. (D) EGPYVGH
of 702.33m/z caused by the loss of one hexose which was selected for additional fragma-DG-derived peptide (LETASPPTR), however, O-mannosylation
could not be substantiated by a-mannosidase treatment (data
not shown).
3.4. Identiﬁcation of T-cadherin as novel O-mannosylated protein
Most interestingly, our analyses revealed two peptides with sig-
niﬁcant intensity ratios that derived from the cell adhesion mole-
cule T-cadherin (T-cad) [22], namely MTAFDADDPATDNALLR and
EGPYVGHVMEGSPTGTTVMR (Fig. 3A). In XIC of mock-treated sam-
ples for both T-cad-derived peptides only the single mannosylated
forms were detected although multiple serine and threonine resi-
dues are present (Figs. S1B and C; and S2C–F). We then took advan-
tage of the ability of an ion trap instrument to perform neutral
loss-triggered MS3 and veriﬁed the identity of these mannosylated
peptides (Fig. 3C and D).
Having recognized T-cad as novel O-mannosylated protein, we
wished to characterize native glycan structures. Therefore, we ana-
lyzed glycopeptides directly after protease digest via LC–MS. Since
our data showed that T-cad peptides are modiﬁed at single posi-
tions (Figs. S1B and C; and S2C–F), we searched for peptide masses
of known O-mannosyl glycan structures [6,23]. Surprisingly, we
observed unmodiﬁed and mono-hexosylated T-cad peptides
(Fig. 4A and B), but no complex glycan structures. In contrast, for
the a-DG peptide VSDAGTVVSGQIR only the complex tetrasaccha-
ride structure was detected (Fig. 4C and D), conﬁrming the results
of previous studies [8,21] and substantiating the ﬁnding of mono-
hexosylated peptides.
So far, our data suggested that T-cad exhibits single O-linked
mannose residues. To further follow this issue, we repeated our
workﬂow but omitted glycosidase treatment of glycopeptides priorskeletal muscle were processed according to the workﬂow in Fig. 1. Signal intensity
ates are shown in a scatter plot. In addition to the internal control peptide DG1man,
: VSDAGTVVSGQIR; and two T-cad-derived peptides MTAFDADDPATDNALLR and
ribed in Fig. 1, but without glycosidase treatment and analyzed as described above.
hexosylated peptides. (C) MTAFDADDPATDNALLR. CID of doubly charged peptide
mass of one hexose. This fragment ion was selected for an additional fragmentation
VMEGSPTGTTVMR. CID of triply charged peptide 756.35m/z leads to a fragment ion
entation.
Fig. 4. T-cad peptides carry single O-linked mannose residues. (A–C) Peptides were prepared without glycosidase treatment and analyzed by LC–MS. XIC are shown. (A and B)
T-cad derived peptides MTAFDADDPATDNALLR (A) and EGPYVGHVMEGSPTGTTVMR (B) are depicted. Only unmodiﬁed and single hexosylated peptides were detected. (C) In
contrast, only the complex glycan structures were detected on a-DG peptide VSDAGTVVSGQIR. (D) Identity of the latter peptide was conﬁrmed by CID of a doubly charged
peptide 1318.13m/z which led to dominant neutral loss of the individual glycans (Hex, HexNAc, Neu5Ac). Also the completely de-glycosylated peptide at 1288.7m/z was
formed.
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tures are retained. As shown in Fig. 3B, both T-cad peptides could
be detected, whereas the tetrasaccharide containing a-DG peptide
was not. Mono-mannosylation and T-cad peptide sequences were
veriﬁed as above (data not shown). Our results show that single
O-linked mannoses of T-cad are not elongated in vivo and thus,
easily accessible for ConA-afﬁnity puriﬁcation of peptides.
In summary, our data demonstrate that T-cad from rabbit skel-
etal muscle is a novel O-mannosylated protein that carries single
O-linked mannose residues. Our method does not allow precise
mapping of mannosylation sites, however speciﬁc serine and thre-
onine residues are highly conserved between T-cadherins from dif-
ferent species and also between other cadherin family members
representing possible O-mannosylation targets (Fig. 5).
4. Discussion
We established a workﬂow that combines a-mannosidase
treatment with MS-based analyses of glycopeptides to conclusively
identify O-mannosylated proteins. In addition, complex carbohy-
drate structures are trimmed back to the initial mannose residue
making analyses of glycoproteins from natural tissues possible.
Especially in combination with electron-transfer dissociation MS
which allows mapping of glycosites, our workﬂow is a powerful
tool for in vivo investigation of O-mannosylated proteins and can
be easily adapted for large scale glycoproteome analyses. Today
those studies are limited towards simple carbohydrate structures
such as O-GlcNAc residues that are not further elongated in vivo
[24] or rely on engineered SimpleCell systems [25].As a proof of principle, we identiﬁed T-cad [22] as a novel target
protein of O-mannosylation which contains single O-linked man-
nose residues. Although early studies on carbohydrates released
from rat brain proteoglycan fractions suggested the presence of
unextended O-linked mannoses [26], no protein carrying this mod-
iﬁcation had been identiﬁed to date.
Cadherins are cell–cell adhesion proteins that are conserved
among vertebrates and invertebrates [27]. In mammals, these
cell-surface glycoproteins play crucial roles in morphogenetic pro-
cesses during embryogenesis, tissue differentiation and mainte-
nance as well as tumor progression [28,29]. Classical vertebrate
cadherins share a conserved cytoplasmic domain, one transmem-
brane domain and an ectodomain containing ﬁve ‘‘extracellular
cadherin’’ (EC) domains [30]. Located on adjacent cells, cadherin
ectodomains form calcium-dependent homophilic interactions
thereby mediating cell–cell adhesion [30]. In contrast to classical
cadherins, the non-canonical T-cad is attached to the plasmamem-
brane via a glycosylphosphatidylinositol (GPI) anchor [22]. Never-
theless, its extracellular domain shares signiﬁcant sequence
similarity with classical cadherins, shows their typical organization
of domains EC1 to EC5 and mediates calcium-dependent, homo-
philic cell adhesion [31]. The 3D crystal structures of T-cad iso-
forms from several vertebrates revealed a typical tandem ß-
sandwich fold of ectodomains EC1 and EC2 [32]. Calcium-ions bind
to and rigidify a ﬂexible interconnecting domain. Molecular con-
tacts between EC1-2 domains of partner T-cad molecules mediate
homodimer binding [32]. Our study identiﬁed O-linked mannose
residues in proximity to EC1-2 contact sites. These O-mannosyla-
tion sites are highly conserved between T-cad isoforms from differ-
Fig. 5. Sites of O-mannosylation are conserved between T-cad and classical cadherins. Multiple sequence alignments, generated with the ClustalW2 algorithm [20]. Regions
covered by the identiﬁed peptides EGPYVGHVMEGSPTGTTVMR and MTAFDADDPATDNALLR are shown. (A and B) Putative O-mannosylation sites are shown as triangles. (A)
Conservation of putative T-cad O-mannosylation sites across species. The following sequences were used: Homo sapiens (P55290), Bos taurus (Q3B7N0), Gallus gallus (P33150),
Danio rerio (F1R6D1), Mus musculus (Q9WTR5), Oryctolagus cuniculus (G1TL92). The loop region participating in partner T-cad interactions is boxed in grey [32]. (B)
Conservation of putative O-mannosylation sites between T-cad and type I cadherins. The following sequences were used: Mus musculus (Q9WTR5), Oryctolagus cuniculus
(G1TL92), Amino acids of EC2 domains are shown. Peptides identiﬁed from rabbit T-cad are underlined. In each peptide only one of these sites is used (Fig. 3A). O-
glycosylation sites detected in 3D crystal structures of E- and N-cadherin [33] are indicated as circles (E-cad) and square (N-cad), respectively.
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structure of ectodomains EC1-5 from mouse E- and N-cadherin
had identiﬁed not further speciﬁed O-linked glycosylation [33]. It
is easy to imagine, that glycosylated serine and threonine residues
correspond to the identiﬁed O-mannosylation sites of T-cad (Fig. 5)
suggesting that protein O-mannosylation is a general feature of
cadherin family members. It has been suggested earlier, that N-
linked glycans might modulate homotypic cadherin interactions
[34]. Likewise, our ﬁndings in the context of highly conserved O-
mannosylation strongly point also to a general role of this modiﬁ-
cation in the functioning of cadherins which to unravel remains a
most challenging task for the future.
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